Forgot Password?

PERSONALIZED MEDICINE IN SEVERE ASTHMA

Applying Emerging Data and Treatments to Everyday Clinical Practice

ENROLL NOW

CME COURSES

This online program includes three individual learning activities featuring leading experts in the field of severe asthma. The intended audience for this course includes: Pulmonologists, Allergists, Primary Care Physicians and other health care professionals who treat patients with severe asthma.

Module 1: Pathophysiology

CME Credit: .50

Learn about the key concepts in the pathophysiology of severe asthma.

Module 2: Current and Emerging Asthma Therapies

CME Credit: .50

Learn about recent clinical data of current and emerging therapies and potential biomarkers for severe asthma.

Module 3: Roundtable Discussion on Personalized Treatment Approaches

CME Credit: .75

We pull together information from the first two modules using a multidisciplinary roundtable discussion with key opinion leaders.

Why Take This Course?

Severe asthma is a leading cause of asthma-related morbidity and mortality. Individuals with severe asthma face excess costs and quality of life constraints far more than those with other manifestations of the disease. In this course, you will learn about the latest evidence-based treatments for severe asthma in addition to a review of established therapies that are essential in helping patients achieve optimal functional status and quality of life. This course will address how you can help patients with severe asthma better understand the importance of using medications properly and consistently.

This online program includes individual learning modules featuring leading experts in the field of severe asthma. The intended audience for this course includes pulmonologists, allergists, primary care physicians and other health care professionals who treat patients with severe asthma.

Each segment of this free CME activity can be done independently of the other for credit.

National Jewish Health
1400 Jackson Street
Denver, CO 80206
© 2017 National Jewish Health


Grant Statement
This educational activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, GlaxoSmithKline, and Sanofi Genzyme and Regeneron Pharmaceuticals.